# ROCURONIUM BROMIDE
> **ANDA220124** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2026-03-04
## Drug
- **FDA Application Number:** ANDA220124
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROCURONIUM BROMIDE
- **Generic name:** Rocuronium Bromide
- **Active ingredients:** ROCURONIUM BROMIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **First approval:** 2026-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220124)
---
*AI Analytics · CC0 1.0*